Why Array Biopharma (NASDAQ:ARRY) have been downgraded?
Array Biopharma Inc (NASDAQ:ARRY) currently trades at $10.61 which is about -5.18% lower than the 52-week high of $11.65. The trading volume at ready counter …
Array Biopharma Inc (NASDAQ:ARRY) currently trades at $10.61 which is about -5.18% lower than the 52-week high of $11.65. The trading volume at ready counter …